Gene: DNAAF9
Official Full Name: dynein axonemal assembly factor 9provided by HGNC
Gene Summary: This gene encodes an uncharacterized protein with a C-terminal coiled-coil region. The gene is located on chromosome 20p13 in a 1.8 Mb region linked to a spinocerebellar ataxia phenotype, but this gene does not appear to be a disease candidate. [provided by RefSeq, Dec 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18244 | DNAAF9 Knockout cell line (HeLa) | Human | DNAAF9 | 1:3~1:6 | Negative | Online Inquiry |
KO18245 | DNAAF9 Knockout cell line (HCT 116) | Human | DNAAF9 | 1:2~1:4 | Negative | Online Inquiry |
KO18246 | DNAAF9 Knockout cell line (HEK293) | Human | DNAAF9 | 1:3~1:6 | Negative | Online Inquiry |
KO18247 | DNAAF9 Knockout cell line (A549) | Human | DNAAF9 | 1:3~1:4 | Negative | Online Inquiry |
DNAAF9 Gene Knockout Cell Lines are specially engineered human cell lines designed to facilitate research on the DNAAF9 gene, which plays a crucial role in ciliary function and respiratory health. These knockout cell lines provide a unique tool for elucidating the mechanisms underlying ciliary motility and the pathophysiology of related diseases, such as primary ciliary dyskinesia. By utilizing CRISPR-Cas9 technology, these cell lines contain precise, heritable modifications that disable the DNAAF9 gene, allowing researchers to study the resulting phenotypic changes in cellular activity, signaling pathways, and overall physiological responses.
The primary function of DNAAF9 is to encode a protein essential for the assembly and stability of cilia, which are vital for cellular movement and sensory functions. By examining the changes observed in DNAAF9 knockout cell lines, researchers can gain insights into the cellular and molecular processes that are disrupted in ciliary dysfunction, paving the way for potential therapeutic interventions. The use of these cell lines is particularly important in both academic and clinical settings, where they serve as a model for understanding diseases associated with ciliary defects and for testing drug efficacy on ciliary-related conditions.
One of the key advantages of DNAAF9 Gene Knockout Cell Lines over alternative models is their specificity; these cell lines allow for targeted investigations of DNAAF9-related pathways without off-target effects, ensuring that data generated is both reliable and reproducible. Additionally, these cell lines are versatile platforms that can be adapted for various experimental approaches, including small molecule screening and genetic modifier studies.
For researchers and clinicians focused on respiratory health or ciliary function, DNAAF9 Gene Knockout Cell Lines represent an essential resource for advancing knowledge and therapeutic strategies in this critical area of study. Our company prides itself on its expertise in developing high-quality biological research tools, offering products that empower scientists to push the boundaries of discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.